What is TOXPIA 200U?
TOXPIA 200U is a Clostridium Botulinum Toxin Type A injectable designed for both aesthetic and medical use. Developed by HJ Corporations in South Korea, this advanced formulation is vacuum-dried for enhanced stability and boasts SEC-HPLC-certified 99% purity.
Available in both 100U and 200U formats, TOXPIA is crafted to meet the diverse needs of modern clinical and cosmetic practices. From glabellar wrinkle treatment to neuromuscular symptom relief, this neurotoxin offers consistent, safe, and fast-acting performance.
Key Benefits at a Glance
Vacuum-Dried Technology – Enhances product integrity during storage and reconstitution
Clinical-Grade Purity (99%) – Reduced immunogenicity and predictable results
Dual Purpose – Ideal for aesthetic & therapeutic applications
Cost-Efficient 200U Format – Treat more patients per vial
Backed by Korean Pharmaceutical R&D – Proven safety, stability, and precision
Who It’s For
- Licensed Dermatologists
- Aesthetic Injectors
- Med Spas and Cosmetic Clinics
- Neurological & Hyperhidrosis Specialists
Educational Insight: How It Works
Botulinum toxin type A is a neurotoxic protein that temporarily blocks acetylcholine, a neurotransmitter responsible for muscle contractions. When injected into targeted areas, it causes muscle relaxation, softening wrinkles and alleviating muscle-related conditions such as:
- Glabellar lines (frown lines)
- Blepharospasm (eyelid spasm)
- Cervical dystonia & spasticity
- Hyperhidrosis (excessive sweating)
Usage & Dosage Guidelines
Detail | Instruction |
Reconstitution | Use 0.9% sodium chloride (saline) under sterile conditions |
Injection Sites | Glabellar area, forehead, underarms, neck, jaw, etc. |
Onset of Action | Results in 3–5 days (average) |
Duration | 3–4 months (individual variation applies) |
Aftercare | Avoid rubbing or lying flat for 4–6 hours post-injection |
Note: Only to be administered by licensed medical professionals.

Competitive Edge: Why Choose TOXPIA?
Feature | TOXPIA 200U | Botox | Rentox |
Purity | 99% (SEC-HPLC) | 95–97% | ~98% |
Drying Method | Vacuum-Dried | Freeze-Dried | Freeze-Dried |
Unit Options | 100U / 200U | 100U | 50U / 100U |
Price Efficiency | High | Moderate | High |
Origin | South Korea | USA | South Korea |
FAQs
Q: Is TOXPIA a botulinum toxin?
A: Yes, it is a Botulinum Toxin Type A injectable product similar in function to Botox.
Q: What sets TOXPIA apart from Botox?
A: TOXPIA offers comparable performance with enhanced purity, vacuum-dried stability, and affordability. It’s especially favored in high-volume clinics seeking consistent results.
Q: What’s the difference between TOXPIA and Rentox?
A: Both are Korean botulinum toxins. TOXPIA is vacuum-dried for extended shelf-life, while Rentox is freeze-dried. Clinical performance is similar, but TOXPIA may offer more stability post-reconstitution.
Q: Is Korean Botox safe?
A: Korean brands like TOXPIA undergo rigorous safety testing and offer high purity, making them globally competitive and increasingly preferred in clinical settings.
Q: Does botulinum toxin enter the bloodstream?
A: No, when injected properly, it acts locally at the neuromuscular junction without systemic absorption.
Final Thoughts
TOXPIA 200U is more than just a wrinkle treatment—it’s a clinical-grade injectable solution that delivers safety, precision, and satisfaction. Whether you’re managing aesthetic outcomes or therapeutic needs, TOXPIA provides the performance, purity, and pricing modern clinics demand.
Reviews
There are no reviews yet.